Clinical Trials
36 trialsA Study of Blood Pressure Control During Cancer Treatment
Memorial Sloan Kettering Cancer Center
G-COR
The Cleveland Clinic
CMR-Onko
Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)
STOP-MED CTRCD
University Health Network, Toronto
BREATHS
University College, London
ML-CardioTox
University Hospital, Caen
SCARA-B
Centre Paul Strauss
BE-FITTER
University of Alberta
HO170DLBCL
Stichting Hemato-Oncologie voor Volwassenen Nederland
BRAVE-HEART
Fondazione IRCCS Policlinico San Matteo di Pavia
HIMALAYAS
University Health Network, Toronto
EMPACT
Maria Sklodowska-Curie National Research Institute of Oncology
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Rutgers, The State University of New Jersey
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
SWOG Cancer Research Network
Cardio CAR-T
Assistance Publique - Hôpitaux de Paris
Cardiac Magnetic Resonance Monitoring of Immune Checkpoint Inhibitor-related Cardiotoxicity
West China Second University Hospital
Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients
Memorial Sloan Kettering Cancer Center
TRUST-ACE
Norwegian University of Science and Technology
Cardio-Onco
University of Bern
HER2BIC
Odense University Hospital
CARTIER
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)
Silesian Centre for Heart Diseases
CV_CANCER
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
CATCH-HF
University of California, San Diego
Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction
Texas Tech University Health Sciences Center
Clinical and Diagnostic Significance of Endothelial Dysfunction and Myocardial Contractility in Patients With AML
Samara State Medical University
PROTECT-COR
Erasmus Medical Center
BLOC-II
University Medical Center Groningen
NT-proBNP to Assess Trastuzumab-induced Cardiotoxicity
Vastra Gotaland Region
LYMfit
Norwegian School of Sport Sciences
Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy
First Hospital of China Medical University
START
Zhejiang Cancer Hospital
COLA
Odense University Hospital
UCARE
National University of Ireland, Galway, Ireland
NARNIA
University Hospital, Akershus
PROTHYM
Swedish Lung Cancer Study Group